| Systematic (IUPAC) name | |
|---|---|
| 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Temporary Class Drug (NZ) |
| Identifiers | |
| CAS number | 335160-66-2 |
| ATC code | ? |
| PubChem | CID 10293794 |
| Chemical data | |
| Formula | C26H34N2O |
| Mol. mass | 390.561 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
AM-1248 is a drug that acts as a moderately potent agonist for both the cannabinoid receptors CB1 and CB2, but with some dispute between sources over its exact potency and selectivity. Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an adamantoyl group, generally confers significant CB2 selectivity,[1] but reasonable CB1 affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position.[2][3] The related compound 1-pentyl-3-(1-adamantoyl)indole was identified as having been sold as a cannabinoid designer drug in Hungary in 2011, along with another synthetic cannabinoid AM-679.[4]
| This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)